Rain Oncology (RAIN) Short Interest Ratio & Short Volume

Short interest is the volume of Rain Oncology shares that have been sold short but have not yet been covered or closed out. As of January 15th, traders have sold 661,100 shares of RAIN short. 2.42% of Rain Oncology's shares are currently sold short. Learn More on Rain Oncology's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RAIN shares currently have a short interest ratio of 3.0. Learn More on Rain Oncology's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.42% of Rain Oncology's floating shares are currently sold short.

Rain Oncology saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 661,100 shares, an increase of 51.4% from the previous total of 436,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Rain Oncology currently has issued a total of 36,380,000 shares. Some of Rain Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Rain Oncology currently has a public float of 27,370,000 shares.

2.42% of Rain Oncology's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Rain Oncology: LianBio (0.36%), Biora Therapeutics, Inc. (4.33%), PMV Pharmaceuticals, Inc. (6.83%), Kinnate Biopharma Inc. (2.01%), NGM Biopharmaceuticals, Inc. (4.52%), Dyadic International, Inc. (0.92%), Beyond Air, Inc. (8.91%), Bionano Genomics, Inc. (8.85%), Rockwell Medical, Inc. (2.40%), Clene Inc. (0.12%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.10 billion), General Motors ($3.90 billion), Charter Communications, Inc. ($3.31 billion), Occidental Petroleum Co. ($2.91 billion), Tractor Supply ($2.75 billion), Moderna, Inc. ($2.44 billion), Coinbase Global, Inc. ($2.10 billion), United Rentals, Inc. ($2.09 billion), Royal Caribbean Cruises Ltd. ($2.03 billion), and Rivian Automotive, Inc. ($1.89 billion). View all of the most shorted stocks.

Short selling RAIN is an investing strategy that aims to generate trading profit from Rain Oncology as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Rain Oncology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RAIN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RAIN, twice per month. The most recent reporting period available is January, 15 2024.